Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04819646 · ClinicalTrials.gov registry record · NA
Evaluate the Effects of a Marine Lipid Oil Concentrate Formulation on Inflammation/Discomfort
A NA study, sponsored by Supplement Formulators.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT04819646: Completed NA study, sponsored by Supplement Formulators.
NCT04819646 is a NA study that has completed, run by Supplement Formulators. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04819646, a NA study, has completed, sponsored by Supplement Formulators.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The purpose of the study is to assess the efficacy and safety of a Marine Lipid Oil Concentrate formulation on inflammation/discomfort and overall well-being in male and female subjects who are generally healthy
Primary Outcome
Assessment of the mean change in the results from the SF-36 Health Survey from baseline
Interventions
- DIETARY_SUPPLEMENT Dietary Supplement
- DIETARY_SUPPLEMENT Marine Lipid Oil Concentrate Formulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2021-01-07 |
| Est. Completion | 2021-11-02 |
| Phase | NA |
What the finished NCT04819646 record still lists
NCT04819646 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Dietary Supplement is the first listed.
NCT04819646 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04819646 about?
NCT04819646 is a clinical study titled "Evaluate the Effects of a Marine Lipid Oil Concentrate Formulation on Inflammation/Discomfort". The purpose of the study is to assess the efficacy and safety of a Marine Lipid Oil Concentrate formulation on inflammation/discomfort and overall well-being in male and female subjects who are generally healthy
What is the current status of trial NCT04819646?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2021-01-07. Estimated completion is 2021-11-02.
What interventions are being tested in trial NCT04819646?
The interventions under investigation include: Dietary Supplement (DIETARY_SUPPLEMENT), Marine Lipid Oil Concentrate Formulation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04819646?
This trial is sponsored by Supplement Formulators, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04819646's enrollment target sits among peer trials
31 1592nd of 2000 higher than 408 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI